本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

34.85
-0.9700-2.71%
盘后34.850.0190+0.05%19:38 EDT
成交量:532.02万
成交额:1.86亿
市值:66.17亿
市盈率:-9.86
高:35.75
开:35.63
低:33.92
收:35.82
数据加载中...
2021/05/11

重要事件披露

8-K - Current report
2021/05/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/15

重要事件披露

8-K - Current report
2021/03/31

重要事件披露

8-K - Current report
2021/02/26

重要事件披露

8-K - Current report
2021/02/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/29

重要事件披露

8-K - Current report
2021/01/26

重要事件披露

8-K - Current report
2021/01/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/26

重要事件披露

8-K - Current report
2021/01/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans